RemeGen Co., Ltd.
REGMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.60 | -0.21 | 0.12 | -1.31 |
| FCF Yield | -24.51% | -14.99% | -3.95% | -0.73% |
| EV / EBITDA | -7.12 | -13.03 | -61.17 | 116.26 |
| Quality | ||||
| ROIC | -28.90% | -31.73% | -20.31% | 4.53% |
| Gross Margin | 79.96% | 76.48% | 64.84% | 95.28% |
| Cash Conversion Ratio | 0.80 | 0.99 | 1.27 | 0.95 |
| Growth | ||||
| Revenue 3-Year CAGR | 30.60% | -8.91% | – | – |
| Free Cash Flow Growth | 38.76% | -16.49% | -471.43% | 69.00% |
| Safety | ||||
| Net Debt / EBITDA | -1.74 | -0.44 | 2.36 | -4.11 |
| Interest Coverage | -18.94 | -65.06 | -156.00 | 30.59 |
| Efficiency | ||||
| Inventory Turnover | 0.52 | 0.34 | 0.52 | 0.24 |
| Cash Conversion Cycle | 662.40 | 1,020.87 | 549.18 | 661.60 |